HC Wainwright Increases Co-Diagnostics (NASDAQ:CODX) Price Target to $3.00

Co-Diagnostics (NASDAQ:CODX – Free Report) had its price target upped by HC Wainwright from $2.00 to $3.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. HC Wainwright also issued estimates for Co-Diagnostics’ Q4 2023 earnings at ($0.20) EPS, FY2023 earnings at ($0.90) EPS, Q1 2024 […]

Related Keywords

United States , ,Koss Olinger Consulting ,Tower Research Capital ,Kestra Advisory Services ,Diagnostics Inc ,Institutional Trading Of Co ,News Ratings For Co ,Dimensional Fund Advisors ,Free Report ,Olinger Consulting ,Research Capital ,Street Group ,Advisory Services ,Fund Advisors ,Get Free Report ,Co Diagnostics Daily ,Co Diagnostics ,Nasdaq Codx ,Codx ,Medical ,Boost Price Target ,Hc Wainwright ,